1.Comparative Evaluation of Hormones and Hormone-Like Molecule in Lineage Specification of Human Induced Pluripotent Stem Cells
Seon A CHOI ; Ju Hyun AN ; Seung Hwan LEE ; Geun Hui LEE ; Hae Jun YANG ; Pil Soo JEONG ; Jae Jin CHA ; Sanghoon LEE ; Young Ho PARK ; Bong Seok SONG ; Bo Woong SIM ; Young Hyun KIM ; Ji Su KIM ; Yeung Bae JIN ; Jae Won HUH ; Sang Rae LEE ; Jong Hee LEE ; Sun Uk KIM
International Journal of Stem Cells 2019;12(2):240-250
BACKGROUND AND OBJECTIVES: Proficient differentiation of human pluripotent stem cells (hPSCs) into specific lineages is required for applications in regenerative medicine. A growing amount of evidences had implicated hormones and hormone-like molecules as critical regulators of proliferation and lineage specification during in vivo development. Therefore, a deeper understanding of the hormones and hormone-like molecules involved in cell fate decisions is critical for efficient and controlled differentiation of hPSCs into specific lineages. Thus, we functionally and quantitatively compared the effects of diverse hormones (estradiol 17-β (E2), progesterone (P4), and dexamethasone (DM)) and a hormone-like molecule (retinoic acid (RA)) on the regulation of hematopoietic and neural lineage specification. METHODS AND RESULTS: We used 10 nM E2, 3 μM P4, 10 nM DM, and 10 nM RA based on their functional in vivo developmental potential. The sex hormone E2 enhanced functional activity of hematopoietic progenitors compared to P4 and DM, whereas RA impaired hematopoietic differentiation. In addition, E2 increased CD34⁺CD45⁺ cells with progenitor functions, even in the CD43⁻ population, a well-known hemogenic marker. RA exhibited lineage-biased potential, preferentially committing hPSCs toward the neural lineage while restricting the hematopoietic fate decision. CONCLUSIONS: Our findings reveal unique cell fate potentials of E2 and RA treatment and provide valuable differentiation information that is essential for hPSC applications.
Dexamethasone
;
Humans
;
Induced Pluripotent Stem Cells
;
Pluripotent Stem Cells
;
Progesterone
;
Regenerative Medicine
;
Tretinoin
2.Modified difficult index adding extremely difficult for fully impacted mandibular third molar extraction
Jae Young KIM ; Hae Sung YONG ; Kwang Ho PARK ; Jong Ki HUH
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2019;45(6):309-315
OBJECTIVES: The aim of this study was to evaluate the validity of the existing classification and difficulty index of impacted mandibular third molars in clinical situations and propose a more practical classification system.MATERIALS AND METHODS: This study included 204 impacted mandibular third molars in 154 patients; panoramic x-ray images were obtained before tooth extraction. Factors including age, sex, and pattern of impaction were investigated. All impacted third molars were classified and scored for spatial relationship (1–5 points), depth (1–4 points), and ramus relationship (1–3 points). All variables were measured twice by the same observer at a minimum interval of one month. Finally, the difficulty index was defined based on the total points scored as slightly difficult (3–4 points), moderately difficult (5–7 points), very difficult (8–10 points), and extremely difficult (11–12 points).RESULTS: The strength of agreement of the total points scored and difficulty index were 0.855 and 0.746, respectively. Most cases were classified as moderately difficult (73.0%). Although only 13 out of 204 cases (6.4%) were classified as extremely difficult, patients classified as extremely difficult were the oldest (P < 0.05).CONCLUSION: For difficulty classification, the authors propose one more difficult category beyond the existing three-step difficulty index: the clinician should consider the patient's age in the difficulty index evaluation.
Classification
;
Humans
;
Molar, Third
;
Tooth Extraction
;
Tooth, Impacted
3.Modified difficult index adding extremely difficult for fully impacted mandibular third molar extraction
Jae Young KIM ; Hae Sung YONG ; Kwang Ho PARK ; Jong Ki HUH
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2019;45(6):309-315
OBJECTIVES:
The aim of this study was to evaluate the validity of the existing classification and difficulty index of impacted mandibular third molars in clinical situations and propose a more practical classification system.
MATERIALS AND METHODS:
This study included 204 impacted mandibular third molars in 154 patients; panoramic x-ray images were obtained before tooth extraction. Factors including age, sex, and pattern of impaction were investigated. All impacted third molars were classified and scored for spatial relationship (1–5 points), depth (1–4 points), and ramus relationship (1–3 points). All variables were measured twice by the same observer at a minimum interval of one month. Finally, the difficulty index was defined based on the total points scored as slightly difficult (3–4 points), moderately difficult (5–7 points), very difficult (8–10 points), and extremely difficult (11–12 points).
RESULTS:
The strength of agreement of the total points scored and difficulty index were 0.855 and 0.746, respectively. Most cases were classified as moderately difficult (73.0%). Although only 13 out of 204 cases (6.4%) were classified as extremely difficult, patients classified as extremely difficult were the oldest (P < 0.05).
CONCLUSION
For difficulty classification, the authors propose one more difficult category beyond the existing three-step difficulty index: the clinician should consider the patient's age in the difficulty index evaluation.
4.Compare the Intracranial Pressure Trend after the Decompressive Craniectomy between Massive Intracerebral Hemorrhagic and Major Ischemic Stroke Patients
Joon HUH ; Seo Yeon YANG ; Han Yong HUH ; Jae Kun AHN ; Kwang Wook CHO ; Young Woo KIM ; Sung Lim KIM ; Jong Tae KIM ; Do Sung YOO ; Hae Kwan PARK ; Cheol JI
Journal of Korean Neurosurgical Society 2018;61(1):42-50
OBJECTIVE: Massive intracerebral hemorrhage (ICH) and major infarction (MI) are devastating cerebral vascular diseases. Decompression craniectomy (DC) is a common treatment approach for these diseases and acceptable clinical results have been reported. Author experienced the postoperative intracranaial pressure (ICP) trend is somewhat different between the ICH and MI patients. In this study, we compare the ICP trend following DC and evaluate the clinical significance.METHODS: One hundred forty-three patients who underwent DC following massive ICH (81 cases) or MI (62 cases) were analyzed retrospectively. The mean age was 56.3±14.3 (median=57, male : female=89 : 54). DC was applied using consistent criteria in both diseases patients; Glasgow coma scale (GCS) score less than 8 and a midline shift more than 6 mm on brain computed tomography. In all patients, ventricular puncture was done before the DC and ICP trends were monitored during and after the surgery. Outcome comparisons included the ictus to operation time (OP-time), postoperative ICP trend, favorable outcomes and mortality.RESULTS: Initial GCS (p=0.364) and initial ventricular ICP (p=0.783) were similar among the ICH and MI patients. The postoperative ICP of ICH patients were drop rapidly and maintained within physiological range if greater than 80% of the hematoma was removed. While in MI patients, the postoperative ICP were not drop rapidly and maintained above the physiologic range (MI=18.8 vs. ICH=13.6 mmHg, p=0.000). The OP-times were faster in ICH patients (ICH=7.3 vs. MI=40.9 hours, p=0.000) and the mortality rate was higher in MI patients (MI=37.1% vs. ICH=17.3%, p=0.007).CONCLUSION: The results of this study suggest that if greater than 80% of the hematoma was removed in ICH patients, the postoperative ICP rarely over the physiologic range. But in MI patients, the postoperative ICP was above the physiologic range for several days after the DC. Authors propose that DC is no need for the massive ICH patient if a significant portion of their hematoma is removed. But DC might be essential to improve the MI patients’ outcome and timely treatment decision.
Brain
;
Cerebral Hemorrhage
;
Cerebral Infarction
;
Decompression
;
Decompressive Craniectomy
;
Glasgow Coma Scale
;
Hematoma
;
Humans
;
Infarction
;
Intracranial Hemorrhages
;
Intracranial Pressure
;
Male
;
Mortality
;
Punctures
;
Retrospective Studies
;
Stroke
;
Vascular Diseases
5.Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
Haeyoung KIM ; Won PARK ; Jeong Il YU ; Doo Ho CHOI ; Seung Jae HUH ; Yeon Joo KIM ; Eun Sook LEE ; Keun Seok LEE ; Han Sung KANG ; In Hae PARK ; Kyung Hwan SHIN ; Chan Woo WEE ; Kyubo KIM ; Kyung Ran PARK ; Yong Bae KIM ; Sung Ja AHN ; Jong Hoon LEE ; Jin Hee KIM ; Mison CHUN ; Hyung Sik LEE ; Jung Soo KIM ; Jihye CHA
Cancer Research and Treatment 2017;49(4):970-980
PURPOSE: This study was conducted to evaluate the impact of supraclavicular lymph node radiotherapy (SCNRT) on N1 breast cancer patients receiving post-lumpectomy whole-breast irradiation (WBI) and anthracycline plus taxane-based (AT) chemotherapy. MATERIALS AND METHODS: We performed a case-control analysis to compare the outcomes of WBI and WBI plus SCNRT (WBI+SCNRT). Among 1,147 patients with N1 breast cancer who received post-lumpectomy radiotherapy and AT-based chemotherapy in 12 hospitals, 542 were selected after propensity score matching. Patterns of failure, disease-free survival (DFS), distant metastasis-free survival (DMFS), and treatment-related toxicity were compared between groups. RESULTS: A total of 41 patients (7.6%) were found to have recurrence. Supraclavicular lymph node (SCN) failure was detected in three patients, two in WBI and one in WBI+SCNRT. All SCN failures were found simultaneously with distant metastasis. There was no significant difference in patterns of failure or survival between groups. The 5-year DFS and DMFS for patients with WBI and WBI+SCNRT were 94.4% versus 92.6% (p=0.50) and 95.1% versus 94.5% (p=0.99), respectively. The rates of lymphedema and radiation pneumonitis were significantly higher in the WBI+SCNRT than in the WBI. CONCLUSION: We did not find a benefit of SCNRT for N1 breast cancer patients receiving AT-based chemotherapy.
Breast Neoplasms*
;
Breast*
;
Case-Control Studies*
;
Disease-Free Survival
;
Drug Therapy*
;
Humans
;
Lymph Nodes
;
Lymphatic Irradiation
;
Lymphedema
;
Mastectomy, Segmental*
;
Neoplasm Metastasis
;
Propensity Score
;
Radiation Pneumonitis
;
Radiotherapy
;
Radiotherapy, Adjuvant
;
Recurrence
6.Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
Yeon Joo KIM ; Won PARK ; Boram HA ; Boram PARK ; Jungnam JOO ; Tae Hyun KIM ; In Hae PARK ; Keun Seok LEE ; Eun Sook LEE ; Kyung Hwan SHIN ; Haeyoung KIM ; Jeong Il YU ; Doo Ho CHOI ; Seung Jae HUH ; Chan Woo WEE ; Kyubo KIM ; Kyung Ran PARK ; Yong Bae KIM ; Sung Ja AHN ; Jong Hoon LEE ; Jin Hee KIM ; Mison CHUN ; Hyung Sik LEE ; Jung Soo KIM ; Jihye CHA
Cancer Research and Treatment 2017;49(4):927-936
PURPOSE: The purpose of this study was to evaluate the impact of postmastectomy radiotherapy (PMRT) on loco-regional recurrence-free survival (LRRFS), disease-free survival (DFS), and overall survival (OS) in pT1-2N1 patients treated with taxane-based chemotherapy. MATERIALS AND METHODS: We retrospectively reviewed the medical data of pathological N1 patients who were treated with modified radical mastectomy and adjuvant taxane-based chemotherapy in 12 hospitals between January 2006 and December 2010. RESULTS: We identified 714 consecutive patients. The median follow-up duration was 69 months (range, 1 to 114 months) and the 5-year LRRFS, DFS, and OS rates were 97%, 94%, and 98%, respectively, in patients who received PMRT (PMRT [+]). The corresponding figures were 96%, 90%, and 96%, respectively, in patients who did not receive PMRT (PMRT [–]). PMRT had no significant impact on survival. Upon multivariable analysis, only the histological grade (HG) was statistically significant as a prognostic factor for LRRFS and DFS. In a subgroup analysis of HG 3 patients, PMRT (+) showed better DFS (p=0.081). CONCLUSION: PMRT had no significant impact on LRRFS, DFS, or OS in pT1-2N1 patients treated with taxane-based chemotherapy. PMRT showed a marginal benefit for DFS in HG 3 patients. Randomized studies are needed to confirm the benefit of PMRT in high risk patients, such as those with HG 3.
Breast Neoplasms*
;
Breast*
;
Disease-Free Survival
;
Drug Therapy*
;
Follow-Up Studies
;
Humans
;
Mastectomy, Modified Radical
;
Radiotherapy*
;
Recurrence
;
Retrospective Studies*
7.The Sewol Ferry Accident and Early Mental Health Care Response by Volunteer Activities of Korean Disaster Mental Health Committee and Members of Korean Neuropsychiatric Association.
Jong Woo PAIK ; Hyun Soo KIM ; Minyoung SIM ; Hae Kook LEE ; Young Sup WOO ; Chanseung CHUNG ; Sang Hyuk LEE ; Jeong Ho SEOK ; Hong Jin JEON ; Sang Min LEE ; Soo Young BANG ; Kyoung Sae NA ; Boung Chul LEE ; Myung Soo LEE ; Hyu Jung HUH ; Jeong Ho CHAE
Journal of Korean Neuropsychiatric Association 2015;54(1):1-5
On 16 April 2014, the Sewol ferry, carrying 476 people, sank in the ocean off the south coast of South Korea. Two hundred and ninety five are confirmed dead and 9 remain missing. The Korean Neuropsychiatric Association (KNPA) set up a Disaster Mental Health Committee (KDMHC) for out-reach services and to provide general strategies for promoting mental health and resilience. Mem bers of KDMHC and Volunteering Psychiatrists of the KNPA had participated in disaster mental health services organized by Gyeonggi-Ansan disaster mental health support team. Their activities were composed of psychoeducation, supportive individual and familial counseling and referring service to professional institutes. This report has described the outline of the initial and acute mental health care responses by KDMHC and volunteers among KNPA members.
Academies and Institutes
;
Counseling
;
Disasters*
;
Korea
;
Mental Health Services
;
Mental Health*
;
Psychiatry
;
Volunteers*
8.Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barre Syndrome in Korea: A Nationwide Multicenter Study.
Jong Kuk KIM ; Jong Seok BAE ; Dae Seong KIM ; Susumu KUSUNOKI ; Jong Eun KIM ; Ji Soo KIM ; Young Eun PARK ; Ki Jong PARK ; Hyun Seok SONG ; Sun Young KIM ; Jeong Geun LIM ; Nam Hee KIM ; Bum Chun SUH ; Tai Seung NAM ; Min Su PARK ; Young Chul CHOI ; Eun Hee SOHN ; Sang Jun NA ; So Young HUH ; Ohyun KWON ; Su Yun LEE ; Sung Hoon LEE ; Sun Young OH ; Seong Hae JEONG ; Tae Kyeong LEE ; Dong Uk KIM
Journal of Clinical Neurology 2014;10(2):94-100
BACKGROUND AND PURPOSE: No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barre syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance. METHODS: Serum was collected from patients during the acute phase of GBS at 20 university-based hospitals in Korea. The clinical and laboratory findings were reviewed and compared with the detected types of anti-ganglioside antibody. RESULTS: Among 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presence of preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence of cranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantly male, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- or anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study. CONCLUSIONS: Anti-ganglioside antibodies were frequently found in the serum of Korean GBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequently misdiagnosed as AIDP by single electrophysiological studies.
Amantadine
;
Antibodies*
;
Axons
;
Cranial Nerves
;
Facial Nerve
;
Guillain-Barre Syndrome*
;
Humans
;
Immunoglobulin G
;
Immunoglobulin M
;
Korea
;
Male
;
Ophthalmoplegia
;
Prevalence*
9.Survey of the Application of the Korean Clinical Practice Recommendations on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society Guidelines.
Geumhee GWAK ; Hae Kyung LEE ; Hee Jung KIM ; Si Youn LEE ; Yong Lai PARK ; Jong Won LEE ; Seung Gi KIM ; Ho HUH ; Hyukjai SHIN ; Je Ryong KIM ; Jin Seok AHN ; Ju Hyuk SON ; Il Gyun LEE ; Woo Chan PARK ; Sung Yong KIM ; Sehwan HAN ; Eun Sook LEE
Journal of Breast Cancer 2012;15(2):239-243
This survey was performed to analyze the usability of the third edition of the Korean breast cancer clinical practice guidelines (KBCCPG) in clinical practice. We made a questionnaire composed of 18 general and 82 specific questions regarding benign breast disease (B; 1 question); non-invasive disease (N; 12 questions); early-stage disease (E; 26 questions); advanced disease (A; 24 questions); and metastatic (M) breast cancer-related problems (19 questions). A total of 100 questionnaires, with a link to an online survey, were delivered via e-mail to over 700 members of the Korean Breast Cancer Society (KBCS), and associated academy members, over 20 days between 26th February and 16th May 2010. Out of 270 respondents who read the e-mail, 96 answered the questionnaire. Participants included 87 surgical oncologists, 5 radiation oncologists, 2 oncoplastic surgeons, 1 pathologist, and 1 medical oncologist. The third KBCCPG were perceived as differing from the second guidelines in terms of the level of clinical evidence required before choosing a recommendation. For the progress of the KBCCPG, the guideline committee should try to reinforce all courses of guideline development with several elements including data from clinical trials of Korean breast cancer patients, securing a multidisciplinary approach, developing consistent and reasonable processes for each step of the revision of the guidelines, induction of liberal scientific and ethical discussion about all issues with all KBCS members. The cost-effectiveness of healthcare and the logical development of the KBCCPG would also be ensured. Timely updates of the clinical guidelines for breast cancer treatment are essential to facilitate optimal decision-making in daily practice, and to ensure adequate patient feedback.
Aluminum Hydroxide
;
Breast
;
Breast Diseases
;
Breast Neoplasms
;
Carbonates
;
Surveys and Questionnaires
;
Delivery of Health Care
;
Dietary Sucrose
;
Electronic Mail
;
Humans
;
Korea
;
Logic
10.The Difference in Aspirin Resistance Based on an Optical Platelet Aggregometer and the PFA-100 in Patients with Acute Ischemic Stroke.
Hyang I PARK ; Hae Jong KIM ; Jae Hyung CHOI ; Dae Hyun KIM ; Jae Tack HUH ; Jae Kwan CHA ; Nam Tae YOO
Korean Journal of Stroke 2011;13(3):114-119
BACKGROUND: There are many causes for the failure of aspirin therapy in patients with acute ischemic stroke. Laboratory aspirin resistance (AR) might be involved in clinical aspirin non-response. The PFA-100 is a laboratory method to evaluate AR in the clinical setting. However, there has been limited data regarding concordance with optical platelet aggregometry, which is considered the gold standard for detecting AR. We retrospectively analyzed platelet function tests using the PFA-100 and an optical platelet aggregometer in 86 patients with acute ischemic stroke. METHODS: Eighty six patients were enrolled in the study and were evaluated the platelet function test by optical aggregometer and a PFA-100. We determined the variability in the prevalence of AR and the kappa value between the two tests in patients with acute ischemic stroke. RESULTS: Among 86 patients, 27 (31.4%) were detected as AR by the optical aggregometer and 31 (36.0%) by the PFA-100. There were 13 cases of AR (15.1%) in both laboratory methods. The optical platelet aggregometer results showed that female gender (P=0.03), aspirin monotherapy (P =0.05), and NIHSS at baseline (P=0.04) were related with AR in acute ischemic stroke. Multiple logistic regression analysis showed that NIHSS was independently associated with AR of the optical platelet aggregometer (OR=1.12 95%, CI: 1.00-1.25, P=0.05). CONCLUSION: The prevalence of AR was similar between the PFA-100 and the optical platelet aggregometer in patients with acute ischemic stroke. However, the concordance rate of these two tools is low.
Aspirin
;
Blood Platelets
;
Female
;
Humans
;
Logistic Models
;
Platelet Aggregation
;
Platelet Function Tests
;
Prevalence
;
Retrospective Studies
;
Stroke

Result Analysis
Print
Save
E-mail